Shannon James Samuel

Shannon James Samuel is listed in filings as Director at MannKind Corporation. This profile follows SEC Form 4 activity through May 22, 2026, including purchase activity. Recent filings connect the profile to MannKind Corporation (MNKD) and Xilio Therapeutics, Inc. (XLO). The current snapshot covers public activity from Jun 17, 2024 to May 22, 2026. Reported amounts are shown as $44.0K to $17.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.